货号 | VK515056 |
---|---|
品牌 | abinScience |
描述 | Lesofavumab is a recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing Lesofavumab (RG6024), a monoclonal antibody, for the treatment of influenza B infections. |
种属反应性 | Influenza B virus |
应用 | Research Grade Biosimilar |
宿主 | Human |
同种型 | IgG1, kappa |
表达系统 | Mammalian Cells |
克隆类型 | Monoclonal |
靶标 | HA/Hemagglutinin |
内毒素水平 | Please contact the lab for this information. |
纯度 | >95% purity as determined by SDS-PAGE. |
纯化方式 | Protein A/G, purified from cell culture supernatant. |
Accession号 | P03461 |
状态 | Liquid |
保存溶液 | 0.01M PBS,pH7.4. |
稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
别名 | RG6024,RG6024,MHAB5553A,RG70026,RO7045557,CAS:1807960-57-1 |
背景 | Lesofavumab (MHAB5553A) is a human IgG1κ anti-influenza B virus antibody. |
Note | For research use only. Not for use in clinical or therapeutic applications. |
SEC-HPLC detection for Research Grade Lesofavumab.
027-87433958/17302791434
武汉东湖新技术开发区神墩四路666号研发楼B区3层东